|
Issuer / Guarantor
|
BridgeBio Pharma Inc
|
|
Size
|
USD 632.5mn
|
|
Type
|
Convertible
|
|
Leads
|
Goldman Sachs, Cantor Fitzgerald, TD Cowen, Evercore, Mizuho Securities, Piper Sandler
|
|
|
|
|
Maturity
|
01 Feb 2033 (7 years)
|
|
Coupon
|
0.75% (0.75 - 1.25%)
|
|
Premium
|
45% (37.5 - 42.5%)
|
|
Calls
|
NC4; PC @ 130% w table MW
|
|
Puts
|
t/o @ 100%
|
|
Div protection
|
Ratio adjustment (Full)
|
|
T/o protection
|
Make-whole table
|
|
CoCo
|
130% to Oct 2032 (6.8 yrs)
|
|
Announced
|
14 Jan 2026
|
Please log in to see more... Login
Please log in to see more... Login
Please log in to see more... Login